Pot Watch: Tilray Inc (TLRY) Is 0.08% Higher Thursday

TLRY, a player in the cannabis market, is higher by 0.08% Thursday as it outperforms the market as a whole. Overall market sentiment has been neutral on Tilray Inc (TLRY) stock lately. TLRY receives a Neutral rating from InvestorsObserver Stock Sentiment Indicator.

Tilray Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on TLRY!

See Full TLRY Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With TLRY Stock Today?

Tilray Inc (TLRY) stock has risen 0.08% while the S&P 500 is lower by -0.25% as of 2:10 PM on Thursday, Sep 16. TLRY is higher by $0.01 from the previous closing price of $12.03 on volume of 6,871,133 shares. Over the past year the S&P 500 has gained 31.40% while TLRY is higher by 127.60%. TLRY lost -$1.36 per share in the over the last 12 months.

More About Tilray Inc

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater. Click Here to get the full Stock Report for Tilray Inc stock.